Replies to post #31 on Dare Bioscience Inc (DARE)

[chmcnfunds]

Hope analysts are correct. I'll take a piece of the target price:

Consensus Ratings for Cerulean Pharma (NASDAQ:CERU)
Ratings Breakdown: 5 Buy Rating(s)
Consensus Rating: Buy (Score: 3.00)
Consensus Price Target: $14.40 (134.15% upside)

_____________________________________


http://www.analystratings.net/stocks/NASDAQ/CERU/

CERU

[chmcnfunds]

Hate Zacks -- kiss of death/loss. They have $7.00 pps which is way off of others.

Another take on analysts:
_________________________________________
Cerulean Pharma Inc.

Snapshot
Average Recommendation: BUY Average Target Price: 16.00
Number of Ratings: 4 Current Quarters Estimate: -0.42
_________________________________________

http://www.marketwatch.com/investing/stock/ceru/analystestimates

CERU